The JLABS: 5 Years of Innovation report quantifies the impact that JLABS and its companies have had on the innovation ecosystem during the past five-years, including investments raised, jobs created and diversity of leadership.
Want to boost your brain power? Researchers at Johns Hopkins think they have a solution.
There are countless programs out there claiming to help improve your brain function. To date, none of them have been proven to be effective. But researchers at Johns Hopkins recently compared two exercises thought to improve brain power, specifically your working memory (not your IQ), which can help you handle a number of work and school-related tasks easier.
The company is working on a therapy for pancreatic cancer using nanotechnology.
OpGen, Inc. (NASDAQ:OPGN) today announced that it has been awarded a contract from the Centers for Disease Control and Prevention (CDC) to develop smartphone-based clinical decision support solutions for antimicrobial stewardship (AMS) and infection control in low- and middle-income countries. The one-year $860,000 award began September 30, 2017 and funds development and evaluation of cloud-based mobile software. OpGen will work with partners Teqqa, LLC and Universidad El Bosque (UEB) of Bogota, Colombia led by Maria Virginia Villegas, M.D., M.Sc.
The University of Maryland BioPark was honored as the Outstanding Research Park of 2017 at the Association of University Research Parks (AURP) International Conference in Huntsville, Ala., on Oct. 11.
American Gene Technologies (AGT), a private Maryland biotechnology company developing cures and treatments for Infectious diseases, cancers and monogenic disorders hosted a ribbon cutting October 23, 2017 celebrating the grand opening of its new 24,000 sq. ft. laboratory and offices. From its new location, AGT will begin clinical trials for its HIV Functional Cure therapeutic in the next six months.
The new AGT expansion will allow for acceleration of gene and cell therapeutic development laboratories supporting the HIV Functional Cure project that is expected to enter the clinic early next year, as well as to sustain the momentum of phenylketonuria and immuno-oncology therapeutics anticipated for clinical activities in late 2019. These early-stage programs represent substantial assets backed by an impressive IP portfolio. The new offices will support the company’s expected growth through early 2020.
TEDCO today announced six finalists for its first-ever Incubator Challenge, a competition created to identify and reward the best ideas for supporting and growing technology companies in Maryland. The finalists will share their ideas with attendees of the 7th Annual Entrepreneur Expo and Stem Cell Symposium on Wednesday, Oct. 25 at the Hilton Baltimore.
United Therapeutics Corporation (NASDAQ: UTHR) today announced approval by the U.S. Food and Drug Administration (FDA) of a new inhalation device, called the TD-300/A, for use with Tyvaso® (treprostinil) Inhalation Solution (Tyvaso).
South Korea must swiftly work to build up a strong medical big data system as it will form the backbone of future medicine led by personalized and predictive health care, biohealth experts in Seoul said Monday.
When the District’s financially troubled 1776 incubator merged with an out-of-town counterpart recently, it became the latest star of Washington’s tech scene to fade away after a few years in the limelight. The sort of permanence that helped make Silicon Valley a top technology hub has largely eluded the region’s start-up incubators.